Iwama H, Nakane M, Ohmori S, Kato M, Kaneko T, Iseki K
Department of Anesthesiology, Central Aizu General Hospital, Aizuwakamatsu, Japan.
J Clin Anesth. 2000 May;12(3):189-95. doi: 10.1016/s0952-8180(00)00137-9.
To assess an anesthetic technique achieving spontaneous breathing through the laryngeal mask airway (LMA) during combined epidural block and propofol anesthesia.
Prospective, consecutive case series study.
Operating room at a general hospital.
112 ASA physical status I and II adult surgery patients; 32 patients for lower extremity surgery are enrolled into study 1, and 30 patients for lower extremity surgery and 50 patients for lower abdominal gynecology surgery are enrolled into study 2.
In study 1, patients were given 1.5 to 2.0 mg/kg followed by a 3 mg/kg/h of infusion of propofol, after epidural block, and they were fitted with the LMA. Thirty minutes after induction, the dose of propofol was increased to 4, 5, 6, and 7 mg/kg/h every 15 minutes. In study 2, the patients were given 1.5 to 2.0 mg/kg and 5 mg/kg/h of propofol and the LMA insertion, after epidural block.
PaO(2)/FIO(2), PaCO(2), tidal volume or respiratory rate, blood pressure, heart rate, and eye opening and motor response scales in conformity with Glasgow coma scale were recorded. Study 1 suggested an induction dose of 1.5 to 2.0 mg/kg and an infusion of 5 mg/kg/h as an appropriate dose to preserve spontaneous breathing with the LMA and to maintain reasonable depth of anesthesia. Study 2 showed that respiratory and circulatory conditions, depth of anesthesia, and other data related to anesthesia were clinically acceptable.
The best infusion dose of propofol to achieve spontaneous breathing with the LMA seems to be 5 mg/kg/h, and the present balanced regional anesthesia with the LMA, using propofol infusion at 1.5 to 2.0 mg/kg and 5 mg/kg/h combined with epidural block, may be useful in clinical practice for lower extremity and lower abdominal gynecologic operations.
评估在硬膜外阻滞联合丙泊酚麻醉期间通过喉罩气道(LMA)实现自主呼吸的麻醉技术。
前瞻性连续病例系列研究。
一家综合医院的手术室。
112例美国麻醉医师协会(ASA)身体状况为I级和II级的成年外科手术患者;32例下肢手术患者纳入研究1,30例下肢手术患者和50例下腹部妇科手术患者纳入研究2。
在研究1中,患者在硬膜外阻滞后给予1.5至2.0mg/kg丙泊酚,随后以3mg/kg/h的速度输注丙泊酚,然后置入LMA。诱导30分钟后,丙泊酚剂量每15分钟增加至4、5、6和7mg/kg/h。在研究2中,患者在硬膜外阻滞后给予1.5至2.0mg/kg丙泊酚和5mg/kg/h的丙泊酚,并置入LMA。
记录动脉血氧分压/吸入氧分数值(PaO₂/FIO₂)、动脉血二氧化碳分压(PaCO₂)、潮气量或呼吸频率、血压、心率以及符合格拉斯哥昏迷量表的睁眼和运动反应评分。研究1表明,诱导剂量为1.5至2.0mg/kg且输注速度为5mg/kg/h是维持LMA自主呼吸并保持合理麻醉深度的合适剂量。研究2表明,呼吸和循环状况、麻醉深度以及其他与麻醉相关的数据在临床上是可接受的。
使用LMA实现自主呼吸的最佳丙泊酚输注剂量似乎为5mg/kg/h,目前采用1.5至2.0mg/kg和5mg/kg/h的丙泊酚输注联合硬膜外阻滞的LMA平衡区域麻醉可能在下肢和下腹部妇科手术的临床实践中有用。